{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:52:46Z","timestamp":1787061166970,"version":"build-2736575974"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015507","name":"Shandong First Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015507","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the clinical characteristics and mechanisms of muscle atrophy in myasthenia gravis (MG) patients who are double-seropositive with acetylcholine receptor (AChR) antibodies and low-density lipoprotein receptor-related protein 4 (LRP4) antibodies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The clinical data, imaging characteristics, treatment methods, and prognosis of one case of MG with AChR\/LRP4 antibodies complicated by muscle atrophy were analyzed. Literature on anti-AChR\/LRP4 antibodies double-seropositive MG with muscle atrophy were reviewed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Clinically, anti-AChR\/LRP4 antibodies double-seropositive MG is rare, often onset after middle age, more common in females, frequently involving bulbar muscles, severe symptoms, poor prognosis, and unrelated to thymoma. Muscle atrophy in MG is not only seen in muscle-specific tyrosine kinase (MuSK)-MG but also in AChR-MG and seronegative MG. The mechanism of muscle atrophy may be related to genetic, immune, and nutritional factors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1545579","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T01:31:32Z","timestamp":1745803892000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Myasthenia gravis with double-seropositive acetylcholine receptor and low-density lipoprotein receptor-related protein 4 antibodies combined with muscle atrophy: a case report and literature review"],"prefix":"10.3389","volume":"16","author":[{"given":"Yue-liang","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gong-zhang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-lu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong-cong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-sheng","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.13592","article-title":"Serological and experimental studies in different forms of myasthenia gravis","volume":"1413","author":"Vincent","year":"2018","journal-title":"Ann N Y Acad Sci"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2013.12.004","article-title":"A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis","volume":"52","author":"Zisimopoulou","year":"2014","journal-title":"J Autoimmun"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/mus.24166","article-title":"Double seropositive myasthenia gravis with acetylcholine receptor and lipoprotein receptor-related protein 4 antibodies","volume":"49","author":"Tsivgoulis","year":"2014","journal-title":"Muscle Nerve"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2017.06.001","article-title":"Double-seropositive myasthenia gravis with acetylcholine receptor and low-density lipoprotein receptor-related protein 4 antibodies associated with invasive thymoma","volume":"27","author":"Ishikawa","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.4708-20","article-title":"A patient with fulminant myasthenia gravis is seropositive for both AChR and LRP4 antibodies, complicated by autoimmune polyglandular syndrome type 3","volume":"59","author":"Inoue","year":"2020","journal-title":"Intern Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2018.07.011","article-title":"Anti-AChR, MuSK, and LRP4 antibodies coexistence: A rare and distinct subtype of myasthenia gravis from Indian subcontinent","volume":"486","author":"Bokoliya","year":"2018","journal-title":"Clin Chim Acta"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13081","article-title":"Electrophysiological findings in patients with low density lipoprotein receptor related protein 4 positive myasthenia gravis","volume":"23","author":"Nikolic","year":"2016","journal-title":"Eur J Neurol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2018.3794","article-title":"Inhibition of autophagy via activation of PI3K\/Akt\/mTOR pathway contributes to the protection of hesperidin against myocardial ischemia\/reperfusion injury","volume":"42","author":"Li","year":"2018","journal-title":"Int J Mol Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s42003-022-03377-x","article-title":"The MFN1 and MFN2 mitofusins promote clustering between mitochondria and peroxisomes","volume":"5","author":"Huo","year":"2022","journal-title":"Commun Biol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1556\/2060.106.2019.07","article-title":"Regulation of Wnt signaling by physical exercise in the cell biological processes of the locomotor system","volume":"106","author":"Hu","year":"2019","journal-title":"Physiol Int"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/bs.pmbts.2017.11.026","article-title":"Wnt signaling in skeletal muscle development and regeneration","volume":"153","author":"Girardi","year":"2018","journal-title":"Prog Mol Biol Transl Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12944-015-0123-1","article-title":"The role of fatty acids in insulin resistance","volume":"14","author":"Sears","year":"2015","journal-title":"Lipids Health Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00577","article-title":"The role of ceramides in insulin resistance","volume":"10","author":"Sokolowska","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.15424","article-title":"Quantifying the inflammatory secretome of human intermuscular adipose tissue","volume":"10","author":"Kahn","year":"2022","journal-title":"Physiol Rep"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.36.2.244","article-title":"Neurogenic muscle involvement in myasthenia gravis. A clinical and histopathological study","volume":"36","author":"Oosterhuis","year":"1973","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/s0385-8146(12)80083-6","article-title":"Atrophy of the tongue with persistent articulation disorder in myasthenia gravis: report of 10 patients","volume":"21","author":"De Assis","year":"1994","journal-title":"Auris Nasus Larynx"},{"key":"B17","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1749-6632.1971.tb30742.x","article-title":"The syndrome of myasthenia and polymyositis with comments on therapy","volume":"183","author":"Johns","year":"1971","journal-title":"Ann N Y Acad Sci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e30015","article-title":"Myasthenia gravis with tongue muscle atrophy: A case series","volume":"10","author":"Zhao","year":"2024","journal-title":"Heliyon"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2005.08.016","article-title":"MuSK antibody positive myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse muscle in vivo","volume":"170","author":"Benveniste","year":"2005","journal-title":"J Neuroimmunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1186\/2044-5040-1-4","article-title":"Regulation of skeletal muscle growth by the IGF1-Akt\/PKB pathway: insights from genetic models","volume":"1","author":"Schiaffino","year":"2011","journal-title":"Skelet Muscle"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1159\/000114286","article-title":"Fine structural studies in myasthenia gravis. II. Lesions of the neuromuscular junction","volume":"10","author":"Korenyi-Both","year":"1973","journal-title":"Eur Neurol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1749-6632.1966.tb45464.x","article-title":"Muscle lesions in myasthenia gravis. Discussion","volume":"135","author":"Engel","year":"1966","journal-title":"Ann\u00a0N Y Acad Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.35.3.311","article-title":"Neurogenic muscle atrophy in myasthenia gravis","volume":"35","author":"Brownell","year":"1972","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000065882.63904.53","article-title":"Clinical aspects of MuSK antibody positive seronegative MG","volume":"60","author":"Sanders","year":"2003","journal-title":"Neurology"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2990.2008.00965.x","article-title":"Muscle\u00a0histopathology in myasthenia gravis with antibodies against MuSK and AChR","volume":"35","author":"Martignago","year":"2009","journal-title":"Neuropathol Appl Neurobiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/j.1442-9071.2011.02727.x","article-title":"Orbicularis oculi: morphological changes mimicking mitochondrial cytopathy in a series of control normal muscles","volume":"40","author":"McKelvie","year":"2012","journal-title":"Clin Exp Ophthalmol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-010-5823-x","article-title":"Comparison of muscle ultrastructure in myasthenia gravis with anti-MuSK and anti-AChR antibodies","volume":"258","author":"Cenacchi","year":"2011","journal-title":"J\u00a0Neurol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1552-6569.2009.00456.x","article-title":"MRI evidence of early muscle atrophy in MuSK positive myasthenia gravis","volume":"21","author":"Zouvelou","year":"2011","journal-title":"J Neuroimaging"},{"key":"B29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.17116\/jnevro202112102179","article-title":"Myasthenia gravis and muscle atrophy","volume":"121","author":"Sanadze","year":"2021","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2015.11.032","article-title":"Reversible tongue muscle atrophy accelerated by early initiation of immunotherapy in anti-MuSK myasthenia gravis: A case report","volume":"360","author":"Kitamura","year":"2016","journal-title":"J Neurol Sci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2012.06833.x","article-title":"The search for new antigenic targets in myasthenia gravis","volume":"1275","author":"Cossins","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135378","article-title":"Flow cytofluorimetric analysis of anti-LRP4 (LDL receptor-related protein 4) autoantibodies in Italian patients with myasthenia gravis","volume":"10","author":"Marino","year":"2015","journal-title":"PLoS One"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1545579\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:19:03Z","timestamp":1761056343000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1545579\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":32,"alternative-id":["10.3389\/fimmu.2025.1545579"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1545579","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"article-number":"1545579"}}